Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML

Jacqueline A. Cook, Loren Lott, Jenna Perry, Ashley M. Eckel, Dongbin Xu, Chad A. Hudson, Denise A. Wells, Michael R. Loken, Andrew J. Menssen

Blood (2024) 144 (5): 581–585.

https://doi.org/10.1182/blood.2024024264

Published: 2024

Includes: Supplemental data

Journal Articles

Residual Mast Cells Can Explain Persistent Molecular Positivity in Difference from Normal Flow Cytometric-Defined MRD Negative Core Binding Factor AML

Jacqueline A. Cook, Loren Lott, Jenna Perry, Arun Nalla, Dongbin Xu, Chad A. Hudson, Denise A. Wells, Michael R. Loken, Andrew J. Menssen

Blood (2023) 142 (Supplement 1): 426.

https://doi.org/10.1182/blood-2023-180275

Published: 2023

Journal Articles

Down Syndrome AML Is Unique in Phenotype Both at Diagnosis and in Post Chemotherapy Regeneration

Elisabeth R Wilson, Lisa Eidenschink Brodersen, PhD, Barbara Katharina Zehentner, PhD, Andrew J. Menssen, Andrew P. Voigt, Laura Pardo, Denise A. Wells, MD, Johann Hitzler, MD FRCP (C), FAAP, Jason N. Berman, MD, Todd A. Alonzo, PhD, Samir B. Kahwash, Soheil Meshinchi, MD PhD, Michael R. Loken, PhD

Blood (2016) 128 (22): 1687.

https://doi.org/10.1182/blood.V128.22.1687.1687

Published: 2016

Journal Articles

MYD88 L265P Mutation Detection: Analysis of Flow Cytometry Sorted Plasma and Lymphoid Cell Clones Improves Sensitivity and Specificity for WM/LPL Diagnosis

Zhixing Wang, PhD, Wayne Fritschle, MT, Richard Bennington, Bettina Burnworth, PhD, Angela Bennington, Collette Wentzel, Stephanie Verkamp, Phung Nguyen, Keely Ghirardelli, Lisa Broderson, PhD, Denise A. Wells, MD, Michael R. Loken, PhD, Barbara Katharina Zehentner, PhD

Blood (2014) 124 (21): 1645.

https://doi.org/10.1182/blood.V124.21.1645.1645

Published: 2014

Journal Articles

SNP/CGH Microarray Analysis in MDS: Correlation with Conventional Cytogenetic, FISH and Flow Cytometry Findings

Barbara Katharina Zehentner, PhD, Lisa Eidenschink Brodersen, PhD, Christine F Stephenson, PhD, FACMG, Jevon Cutler, Monica E. de Baca, MD, Andrew Menssen, Kelle Hammock, Krystal Johnson, MS, Luise Hartmann, MS, Michael R Loken, PhD, Denise A. Wells, MD

Blood (2014) 124 (21): 5592.

https://doi.org/10.1182/blood.V124.21.5592.5592

Published: 2014

Journal Articles

Lineage-Specific Distribution of CALR EXON 9, JAK2V617F, MPLW515L/K, NPM1 and FLT3 Mutations in Myeloid Disorders

Bettina Burnworth, PhD, Richard Bennington, Wayne Fritschle, MT, Phung Nguyen, Stephanie Verkamp, Bennington Angela, MB (ASCP), Collette Wentzel, Lisa Broderson, PhD, Michael R. Loken, PhD, Denise A. Wells, MD, Barbara Katharina Zehentner, PhD

Blood (2014) 124 (21): 5573.

https://doi.org/10.1182/blood.V124.21.5573.5573

Published: 2014

Journal Articles

A Comparative Assessment of Flow Cytometric Scoring Systems in MDS

Lisa Eidenschink Brodersen, PhD, Andrew Menssen, Barbara Katharina Zehentner, PhD, Christine F Stephenson, PhD, FACMG, Monica E. de Baca, MD, Krystal Johnson, MS, Timothy Singleton, MD, Luise Hartmann, MS, Michael R. Loken, PhD, Denise A. Wells, MD

Blood (2014) 124 (21): 5589.

https://doi.org/10.1182/blood.V124.21.5589.5589

Published: 2014

Journal Articles

Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes.

Barbara Katharina Zehentner, PhD, Jevon Cutler, Luise Hartmann, MS, Krystal Johnson, MS, Richard Bennington, Wayne Fritschle, MT, Keely Ghirardelli, Lisa Broderson, PhD, Doug Chapman, Christine F Stephenson, PhD, FACMG, Monica E de Baca, MD, Timothy Singleton, MD, Denise A. Wells, MD, Michael R. Loken, PhD

Blood (2014) 124 (21): 3244.

https://doi.org/10.1182/blood.V124.21.3244.3244

Published: 2014

Journal Articles

Sub-Morphologic Evidence of Disease Prior to Stem Cell Transplantation Correlates with Inferior Post Transplant Outcome in Childhood Acute Myeloid Leukemia.

Abby R. Rosenberg, MD, Wendy Leisenring, Sc.D., Jean E Sanders, MD, Ann E Woolfrey, MD, Paul A. Carpenter, MD, Denise A. Wells, MD, Michael R. Loken, PhD, Soheil Meshinchi, MD, PhD

Blood (2009) 114 (22): 328.

https://doi.org/10.1182/blood.V114.22.328.328

Published: 2009

Journal Articles

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

Bart L. Scott, Denise A. Wells, Michael R. Loken, David Myerson, Wendy M. Leisenring, H. Joachim Deeg

Blood (2008) 112 (7): 2681–2686.

https://doi.org/10.1182/blood-2008-05-153700

Published: 2008

Journal Articles

Myeloid Dyspoiesis as Determined by Flow Cytometry Is a More Powerful Predictor of Post-Transplant Relapse with MDS Than the Marrow Myeloblast Count.

Denise A. Wells, MD, Bart L. Scott, MD, Wendy M. Leisenring, PhD, Michael R. Loken, PhD, H. Joachim Deeg, MD

Blood (2007) 110 (11): 1656.

https://doi.org/10.1182/blood.V110.11.1656.1656

Published: 2007

Journal Articles

Correcting Flow Cytometric Blast Counts for Blood Contamination in Bone Marrow Aspirates.

Michael R. Loken, PhD, Sung-Chao Chu, MD, Wayne K. Fritschle, MT(ASCP), Dian-Kun Li, MD, Denise A. Wells, MD

Blood (2007) 110 (11): 4613.

https://doi.org/10.1182/blood.V110.11.4613.4613

Published: 2007

Journal Articles

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

Denise A. Wells, Martin Benesch, Michael R. Loken, Carlos Vallejo, David Myerson, Wendy M. Leisenring, H. Joachim Deeg

Blood (2003) 102 (1): 394–403.

https://doi.org/10.1182/blood-2002-09-2768

Published: 2003

NARROW

Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML

Residual Mast Cells Can Explain Persistent Molecular Positivity in Difference from Normal Flow Cytometric-Defined MRD Negative Core Binding Factor AML

Down Syndrome AML Is Unique in Phenotype Both at Diagnosis and in Post Chemotherapy Regeneration

MYD88 L265P Mutation Detection: Analysis of Flow Cytometry Sorted Plasma and Lymphoid Cell Clones Improves Sensitivity and Specificity for WM/LPL Diagnosis

SNP/CGH Microarray Analysis in MDS: Correlation with Conventional Cytogenetic, FISH and Flow Cytometry Findings

Lineage-Specific Distribution of CALR EXON 9, JAK2V617F, MPLW515L/K, NPM1 and FLT3 Mutations in Myeloid Disorders

A Comparative Assessment of Flow Cytometric Scoring Systems in MDS

Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes.

Sub-Morphologic Evidence of Disease Prior to Stem Cell Transplantation Correlates with Inferior Post Transplant Outcome in Childhood Acute Myeloid Leukemia.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

Myeloid Dyspoiesis as Determined by Flow Cytometry Is a More Powerful Predictor of Post-Transplant Relapse with MDS Than the Marrow Myeloblast Count.

Correcting Flow Cytometric Blast Counts for Blood Contamination in Bone Marrow Aspirates.

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only